Related Experiment Video
Updated: Feb 11, 2026

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
Published on: November 23, 2019
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
Yann Estornes1,2,3, Yves Dondelinger1,2, Kathrin Weber1,2,3
1VIB Center for Inflammation Research, Technologiepark 927, Zwijnaarde-Ghent, 9052, Belgium.
Abstract:
The sensitivity of cells to death receptor-induced apoptosis is commonly controlled by multiple checkpoints in order to limit induction of excessive or unnecessary death. Although cytotoxic in various cancer cells, tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) does not trigger apoptosis in most non-transformed cells. The molecular nature of the checkpoints that normally protect the cells from TRAIL-induced death are not fully understood. Endoplasmic reticulum (ER) stress has been reported to switch the sensitivity of human cells to the cytotoxic effect of TRAIL, suggesting that this cellular state perturbs some of these protective mechanisms. We found that tunicamycin (TU), but no other ER stress inducers, sensitized mouse fibroblasts and hippocampal neuronal cells to TRAIL-induced apoptosis. Importantly, the sensitization was specific to TRAIL and not caused by differences in ER stress induction. Instead, it relied on the inhibition of N-glycosylation of the mouse TRAIL receptor (mTRAIL-R). Inhibition of N-glycosylation did not alter cell surface expression of mTRAIL-R but enhanced its ability to bind TRAIL, and facilitated mTRAIL-R oligomerization, which resulted in enhanced death-inducing signaling complex (DISC) formation and caspase-8 activation. Remarkably, reconstitution of mTRAIL-R-deficient cells with a version of mTRAIL-R mutated for the three N-glycosylation sites identified in its ectodomain confirmed higher sensitivity to TRAIL-induced apoptosis. Together, our results demonstrate that inhibition of N-glycosylation of mTRAIL-R, and not ER stress induction, sensitizes mouse cells to TRAIL-induced apoptosis. We therefore reveal a new mechanism restraining TRAIL cytotoxicity in mouse cells.
Insights
Cellular sensitivity to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is regulated by checkpoints. We found that inhibiting N-glycosylation of the mouse TRAIL receptor (mTRAIL-R) sensitizes cells to TRAIL-induced apoptosis.
Area of Science:
- Cellular and Molecular Biology
- Immunology
- Apoptosis Research
Background:
- Cellular sensitivity to apoptosis, particularly via death receptors like tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), is tightly regulated by protective checkpoints.
- While TRAIL is cytotoxic to cancer cells, most normal cells resist its apoptotic effects, with the underlying protective mechanisms not fully elucidated.
- Endoplasmic reticulum (ER) stress has been implicated in altering cellular sensitivity to TRAIL, suggesting a role in modulating these protective checkpoints.
Purpose of the Study:
- To investigate the molecular mechanisms by which cells are protected from TRAIL-induced apoptosis.
- To determine if ER stress influences cellular sensitivity to TRAIL and to identify the specific pathways involved.
- To elucidate the role of N-glycosylation of the mouse TRAIL receptor (mTRAIL-R) in regulating TRAIL-induced apoptosis.
Main Methods:
- Treatment of mouse fibroblasts and hippocampal neuronal cells with tunicamycin (TU) and other ER stress inducers, followed by exposure to TRAIL.
- Analysis of mTRAIL-R N-glycosylation status, cell surface expression, TRAIL binding affinity, and oligomerization.
- Assessment of death-inducing signaling complex (DISC) formation and caspase-8 activation.
- Reconstitution experiments using mTRAIL-R deficient cells expressing wild-type or mutated mTRAIL-R (lacking N-glycosylation sites).
Main Results:
- Tunicamycin (TU), an inhibitor of N-glycosylation, specifically sensitized mouse cells to TRAIL-induced apoptosis, while other ER stress inducers did not.
- The sensitization was attributed to the inhibition of N-glycosylation of mTRAIL-R, which enhanced TRAIL binding and receptor oligomerization.
- This led to increased DISC formation and caspase-8 activation, ultimately promoting apoptosis.
- Mutational analysis confirmed that N-glycosylation sites on mTRAIL-R are critical for its resistance to TRAIL-induced apoptosis.
Conclusions:
- Inhibition of N-glycosylation of the mouse TRAIL receptor (mTRAIL-R), rather than ER stress induction itself, is a key mechanism sensitizing mouse cells to TRAIL-induced apoptosis.
- This study reveals a novel checkpoint involving mTRAIL-R N-glycosylation that restrains TRAIL cytotoxicity in non-transformed cells.
- Understanding this mechanism could offer new therapeutic strategies targeting TRAIL sensitivity in various cellular contexts.
Related Concept Videos
Protein Glycosylation
Glycosylation occurs in...
Apoptosis
Uncertainty in Measurement: Significant Figures
Inflammation
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Induced Pluripotent Stem Cells

